David Male

Prof. David Male


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
BWB. B. Weksler
B. B. Weksler
ESE. A. Subileau
E. A. Subileau
NPN. Perrière
N. Perrière
PCP. Charneau
P. Charneau
KHK. Holloway
K. Holloway
PCP. O. Couraud
P. O. Couraud

6 March 2014 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MLMiguel Alejandro Lopez‐Ramirez
Miguel Alejandro Lopez‐Ramirez
DWDongsheng Wu
Dongsheng Wu
GPGareth Pryce
Gareth Pryce
JSJulie E. Simpson
Julie E. Simpson
ARArie Reijerkerk
Arie Reijerkerk
IRIgnacio Romero
Ignacio Romero
Blood–brain barrier (BBB) dysfunction is a hallmark of neurological conditions such as multiple sclerosis (MS) and stroke. However, the molecular mechanisms underlying neurovascular dysfunction during BBB breakdown remain elusive. MicroRNAs (miRNAs) have recently emerged as key regulators of pathogenic responses, although their role in central nervous system (CNS) microvascular disorders is largely unknown. We have identified miR‐155 as a critical miRNA in neuroinflammation at the BBB. miR‐155 is expressed at the neurovascular unit of individuals with MS and of mice with experimental autoimmune encephalomyelitis (EAE). In mice, loss of miR‐155 reduced CNS extravasation of systemic tracers, both in EAE and in an acute systemic inflammation model induced by lipopolysaccharide. In cultured human brain endothelium, miR‐155 was strongly and rapidly upregulated by inflammatory cytokines. miR‐155 up‐regulation mimicked cytokine‐induced alterations in junctional organization and permeability, whereas inhibition of endogenous miR‐155 partially prevented a cytokine‐induced increase in permeability. Furthermore, miR‐155 modulated brain endothelial barrier function by targeting not only cell–cell complex molecules such as annexin‐2 and claudin‐1, but also focal adhesion components such as DOCK‐1 and syntenin‐1. We propose that brain endothelial miR‐155 is a negative regulator of BBB function that may constitute a novel therapeutic target for CNS neuroinflammatory disorders.—Lopez‐Ramirez, M. A., Wu, D., Pryce, G., Simpson, J. E., Reijerkerk, A., King‐Robson, J., Kay, O, de Vries, H. E., Hirst, M. C., Sharrack, B., Baker D., Male, D. K., Michael, G. J., Romero, I. A. MicroRNA‐155 negatively affects blood–brain barrier function during neuroinflammation. FASEB J . 28, 2551–2565 (2014). www.fasebj.org

1 March 2003 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
GFGeraldine Flynn
Geraldine Flynn
SMSeema Maru
Seema Maru
JLJane Loughlin
Jane Loughlin
IRIgnacio Romero
Ignacio Romero
DMDavid Male
David Male

5 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RGRadka Gromnicova
Radka Gromnicova
HDHeather A. Davies
Heather A. Davies
PSPeddagangannagari Sreekanthreddy
Peddagangannagari Sreekanthreddy
IRIgnacio Romero
Ignacio Romero
TLTorben Lund
Torben Lund
DMDavid Male
David Male
The blood-brain barrier prevents the entry of many therapeutic agents into the brain. Various nanocarriers have been developed to help agents to cross this barrier, but they all have limitations, with regard to tissue-selectivity and their ability to cross the endothelium. This study investigated the potential for 4 nm coated gold nanoparticles to act as selective carriers across human brain endothelium and subsequently to enter astrocytes. The transfer rate of glucose-coated gold nanoparticles across primary human brain endothelium was at least three times faster than across non-brain endothelia. Movement of these nanoparticles occurred across the apical and basal plasma membranes via the cytosol with relatively little vesicular or paracellular migration; antibiotics that interfere with vesicular transport did not block migration. The transfer rate was also dependent on the surface coating of the nanoparticle and incubation temperature. Using a novel 3-dimensional co-culture system, which includes primary human astrocytes and a brain endothelial cell line hCMEC/D3, we demonstrated that the glucose-coated nanoparticles traverse the endothelium, move through the extracellular matrix and localize in astrocytes. The movement of the nanoparticles through the matrix was >10 µm/hour and they appeared in the nuclei of the astrocytes in considerable numbers. These nanoparticles have the correct properties for efficient and selective carriers of therapeutic agents across the blood-brain barrier.

24 November 2003 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
PHP. Hillyer
P. Hillyer
EME. Mordelet
E. Mordelet
GFG. Flynn
G. Flynn
DMDavid Male
David Male

15 September 2012 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MLM. Alejandro Lopez-Ramirez
M. Alejandro Lopez-Ramirez
RFRoman Fischer
Roman Fischer
CTClaudia C. Torres-Badillo
Claudia C. Torres-Badillo
HDHeather A Davies
Heather A Davies
KLKaren Logan
Karen Logan
IRIgnacio Romero
Ignacio Romero
During neuroinflammation, cytokines such as TNF-α and IFN-γ secreted by activated leukocytes and/or CNS resident cells have been shown to alter the phenotype and function of brain endothelial cells (BECs) leading to blood–brain barrier breakdown. In this study, we show that the human BEC line hCMEC/D3 expresses the receptors for TNF-α, TNF receptor 1 and TNF receptor 2, and for IFN-γ. BEC activation with TNF-α alone or in combination with IFN-γ induced endothelial leakage of paracellular tracers. At high cytokine concentrations (10 and 100 ng/ml), this effect was associated with caspase-3/7 activation and apoptotic cell death as evidenced by annexin V staining and DNA fragmentation (TUNEL) assays. In addition, inhibition of JNK and protein kinase C activation at these doses partially prevented activation of caspase-3/7, although only JNK inhibition was partially able to prevent the increase in BEC paracellular permeability induced by cytokines. By contrast, lower cytokine concentrations (1 ng/ml) also led to effector caspase activation, increased paracellular flux, and redistribution of zonula occludens-1 and VE-cadherin but failed to induce apoptosis. Under these conditions, specific caspase-3 and caspase-9, but not caspase-8, inhibitors partially blocked cytokine-induced disruption of tight and adherens junctions and BEC paracellular permeability. Our results suggest that the concentration of cytokines in the CNS endothelial microenvironment determines the extent of caspase-mediated barrier permeability changes, which may be generalized as a result of apoptosis or more subtle as a result of alterations in the organization of junctional complex molecules.